OnabotulinumtoxinA in Resistant Depression: A Randomized Trial Comparing Two Facial Injection Sites (OnaDEP Study).

At week 12, there were 14/27 responders (51.9%) in the glabella group and 9/26 (34.6%) in the crow's feet group, which did not reach statistical significance ( p =0.206, χ 2 ) ( Figure 2 ). 3.4.

also in 111,027 other papers